Psychemedics Corporation Launches New Ketamine Hair Testing Service

Rhea-AI Summary

Psychemedics (NASDAQ: PMD), a leader in hair testing, has launched a new ketamine hair testing service. This innovative solution offers a 90-day detection window, non-invasive collection, and high accuracy. Key features include:

• Long detection window up to 90 days
• Non-invasive and convenient collection process
• High sensitivity and specificity
• Integration with existing multi-drug panels
• Applicability across various industries

The service aims to address the growing concern of ketamine abuse in workplaces, educational institutions, and law enforcement. CEO Brian Hullinger emphasized the company's commitment to providing reliable drug testing solutions for maintaining safe environments.

Positive

• Introduction of new ketamine hair testing service expanding product portfolio
• Long detection window of up to 90 days, offering comprehensive drug use history
• Non-invasive and convenient testing method, potentially increasing adoption
• High sensitivity and specificity, minimizing false positives and negatives
• Integration capability with existing multi-drug panels, enhancing overall testing offerings

Negative

• None.

DALLAS, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in hair testing, is proud to announce the launch of its new ketamine hair testing solution. This innovative testing method marks a significant advancement in the detection and prevention for a drug-free workplace and community.

Ketamine, a powerful dissociative anesthetic and emerging drug of abuse, poses a growing concern for employers, educators, and law enforcement agencies. With the introduction of this new testing service, Psychemedics aims to equip organizations with the tools needed to identify and address ketamine use effectively.

Key Features and Benefits of Ketamine Hair Testing

1. Long Detection Window: Unlike traditional drug testing methods, hair analysis can detect ketamine use for up to 90 days, providing a comprehensive overview of an individual’s drug use history.
2. Non-Invasive and Convenient: The hair collection process is simple and noninvasive and can be performed without the need for specialized facilities, making it ideal for various testing environments.
3. High Sensitivity and Specificity: Utilizing advanced technology, Psychemedics’ ketamine hair test ensures highly accurate results, minimizing the risk of false positives and negatives.
4. Comprehensive Drug Panel: This new service can be integrated into existing multi-drug panels offered by Psychemedics, allowing for a broad-spectrum approach to drug testing.
5. Support for Various Industries: The ketamine hair test is designed to meet the needs of diverse sectors, including workplace safety programs, educational institutions, rehabilitation centers, law enforcement agencies, and many others.
   

“We are thrilled to introduce ketamine hair testing as part of our commitment to delivering the most reliable and comprehensive drug testing solutions,” said Brian Hullinger, CEO and President of Psychemedics. “This new offering underscores our dedication to innovation and our mission to support organizations in maintaining safe and drug-free environments.”

Psychemedics’ ketamine hair testing service is now available to clients and partners. For more information about this new service or to schedule a consultation, please contact Psychemedics at info@psychemedics.com or visit our website at https://www.psychemedics.com.

About Psychemedics 

Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.

Investor Relations:
Phone: 978-206-8220
Email: InvestorRelations@psychemedics.com 

FAQ

What is the new service launched by Psychemedics (PMD) in August 2024?

Psychemedics (PMD) launched a new ketamine hair testing service in August 2024, offering a 90-day detection window for ketamine use.

How long can Psychemedics' (PMD) new ketamine hair test detect drug use?

Psychemedics' (PMD) new ketamine hair test can detect ketamine use for up to 90 days, providing a comprehensive overview of an individual's drug use history.

What industries can benefit from Psychemedics' (PMD) ketamine hair testing service?

Psychemedics' (PMD) ketamine hair testing service can benefit workplace safety programs, educational institutions, rehabilitation centers, law enforcement agencies, and other sectors requiring drug testing.

What are the key features of Psychemedics' (PMD) new ketamine hair test announced in 2024?

Key features of Psychemedics' (PMD) new ketamine hair test include a 90-day detection window, non-invasive collection, high sensitivity and specificity, and integration capability with existing multi-drug panels.